Thierry Vernier
Directeur/Membre du Conseil chez Bioverativ Therapeutics, Inc.
Profil
Thierry Vernier is currently a Director at Bioverativ Therapeutics, Inc. He previously worked as a Vice President-Financial Control & Plan at Sanofi from 2004 to 2013.
He is a graduate of Ecole de Management de Normandie.
Postes actifs de Thierry Vernier
| Sociétés | Poste | Début |
|---|---|---|
Bioverativ Therapeutics, Inc.
 Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | - |
Anciens postes connus de Thierry Vernier
| Sociétés | Poste | Fin |
|---|---|---|
| SANOFI | Comptroller/Controller/Auditor | 21/06/2012 |
Formation de Thierry Vernier
| Ecole de Management de Normandie | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SANOFI | Health Technology |
| Entreprise privées | 1 |
|---|---|
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Health Technology |